Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients

J Antimicrob Chemother. 2009 May;63(5):1080; author reply 1080-1. doi: 10.1093/jac/dkn556. Epub 2009 Jan 21.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • HIV Infections / drug therapy*
  • Humans
  • Lamivudine / therapeutic use*
  • Nevirapine / therapeutic use*
  • Organophosphonates / therapeutic use*
  • Tenofovir
  • Treatment Failure
  • Viral Load

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Lamivudine
  • Nevirapine
  • Tenofovir
  • Adenine